Dallas-based Baylor Scott & White Health reported an operating income of $1.7 billion (10% margin) in the fiscal year ending June 30, 2025, up more than 41% from the $1.2 billion gain (7.9% margin) posted in the previous fiscal year.
Five things to know:
1. Revenue for the 53-hospital system increased 11.6% year over year to $17.3 billion, according to financial documents published Oct. 31. Net patient service revenue rose 12% to $13.5 billion.
2. Operating expenses increased 9.1% year over year, reaching $15.6 billion. The largest line items were salaries, wages and employee benefits ($7 billion), followed by supplies ($2.7 billion) and other operating expenses ($3.5 billion).
3. After accounting for nonoperating items, such as investment returns, Baylor Scott & White Health reported a net income of $2.7 billion in fiscal 2025, compared to a $2 billion net gain in fiscal 2024.
4. Baylor Scott & White generated $2.5 billion in net cash from operating activities, compared to $2.3 billion in fiscal 2024. The system ended the year with $2.5 billion in cash and cash equivalents.
5. As of June 30, 2025, the health system had $3.9 billion in long-term debt and $22.9 billion in net assets.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
